FI971674A0 - Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina - Google Patents
Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineinaInfo
- Publication number
- FI971674A0 FI971674A0 FI971674A FI971674A FI971674A0 FI 971674 A0 FI971674 A0 FI 971674A0 FI 971674 A FI971674 A FI 971674A FI 971674 A FI971674 A FI 971674A FI 971674 A0 FI971674 A0 FI 971674A0
- Authority
- FI
- Finland
- Prior art keywords
- tert
- useful
- heterocyclic group
- compounds containing
- inflammatory agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/326,619 US5510361A (en) | 1994-10-20 | 1994-10-20 | Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
PCT/US1995/012878 WO1996012710A1 (en) | 1994-10-20 | 1995-10-18 | Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
Publications (2)
Publication Number | Publication Date |
---|---|
FI971674A0 true FI971674A0 (fi) | 1997-04-18 |
FI971674A FI971674A (fi) | 1997-04-18 |
Family
ID=23272988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI971674A FI971674A (fi) | 1994-10-20 | 1997-04-18 | Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina |
Country Status (8)
Country | Link |
---|---|
US (1) | US5510361A (fi) |
EP (1) | EP0787130A1 (fi) |
JP (1) | JPH10507754A (fi) |
KR (1) | KR100226509B1 (fi) |
AU (1) | AU705645B2 (fi) |
FI (1) | FI971674A (fi) |
NO (1) | NO971789L (fi) |
WO (1) | WO1996012710A1 (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4408084A1 (de) * | 1994-03-10 | 1995-09-14 | Hoechst Ag | 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
JP3588734B2 (ja) * | 1996-07-26 | 2004-11-17 | コニカミノルタホールディングス株式会社 | 電子写真感光体 |
US5985930A (en) | 1996-11-21 | 1999-11-16 | Pasinetti; Giulio M. | Treatment of neurodegenerative conditions with nimesulide |
US20030129186A1 (en) | 2001-07-25 | 2003-07-10 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
EP1430017A2 (en) * | 2001-09-26 | 2004-06-23 | Theravance, Inc. | Substituted phenol compounds useful for anesthesia and sedation |
US6555563B1 (en) | 2001-11-16 | 2003-04-29 | Medinox, Inc. | Heteroaryl substituted amidinyl and imidazolyl compounds and methods employing same for the treatment of inflammation |
US7479507B2 (en) * | 2003-01-14 | 2009-01-20 | Adam Heller | Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs |
US20050003024A1 (en) * | 2003-03-04 | 2005-01-06 | The Procter & Gamble Company | Regulation of mammalian hair growth |
US20050255059A1 (en) * | 2004-05-10 | 2005-11-17 | Oblong John E | Personal care compositions and methods regulating mammalian hair growth |
US20050255060A1 (en) * | 2004-05-10 | 2005-11-17 | Oblong John E | Personal care compositions and methods regulating mammalian hair growth |
SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
US20070203240A1 (en) * | 2006-02-27 | 2007-08-30 | The Procter & Gamble Company | Personal care compositions and methods for regulating mammalian hair growth |
EP2063905B1 (en) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
CA2895287A1 (en) | 2013-03-14 | 2014-10-02 | Dart Neuroscience, Llc | Substituted naphthyridine and quinoline compounds as mao inhibitors |
US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT364354B (de) * | 1976-10-14 | 1981-10-12 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren |
US4535165A (en) * | 1981-11-23 | 1985-08-13 | Riker Laboratories, Inc. | Substituted diazoles and thiazoles |
JPS58148858A (ja) * | 1982-02-26 | 1983-09-05 | Yamanouchi Pharmaceut Co Ltd | 3,5−ジ−tert−ブチル−4−ヒドロキシフエニル置換複素環化合物 |
IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
JPH0615542B2 (ja) * | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
US4724246A (en) * | 1986-12-10 | 1988-02-09 | Ciba-Geigy Corporation | Substituted 1,3,4-oxathiazol-2-one stabilizers |
DE3702758A1 (de) * | 1987-01-30 | 1988-09-29 | Hoechst Ag | Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte |
DE3702757A1 (de) * | 1987-01-30 | 1988-08-11 | Hoechst Ag | Neue imidazo- und triazolo-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte |
DE3702756A1 (de) * | 1987-01-30 | 1988-08-11 | Hoechst Ag | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2- amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
JPH01180878A (ja) * | 1988-01-11 | 1989-07-18 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピラゾール化合物 |
US5155122A (en) * | 1988-11-29 | 1992-10-13 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents |
JPH02229169A (ja) * | 1989-03-01 | 1990-09-11 | Takeda Chem Ind Ltd | ピラゾロン誘導体 |
DE3918979A1 (de) * | 1989-06-10 | 1990-12-13 | Basf Ag | Verfahren zur herstellung von pyrazol und dessen derivaten |
DE4408084A1 (de) * | 1994-03-10 | 1995-09-14 | Hoechst Ag | 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1994
- 1994-10-20 US US08/326,619 patent/US5510361A/en not_active Expired - Fee Related
-
1995
- 1995-10-18 KR KR1019970702584A patent/KR100226509B1/ko not_active IP Right Cessation
- 1995-10-18 JP JP8513964A patent/JPH10507754A/ja active Pending
- 1995-10-18 EP EP95936860A patent/EP0787130A1/en not_active Withdrawn
- 1995-10-18 WO PCT/US1995/012878 patent/WO1996012710A1/en not_active Application Discontinuation
- 1995-10-18 AU AU38598/95A patent/AU705645B2/en not_active Ceased
-
1997
- 1997-04-18 FI FI971674A patent/FI971674A/fi unknown
- 1997-04-18 NO NO971789A patent/NO971789L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO971789D0 (no) | 1997-04-18 |
AU705645B2 (en) | 1999-05-27 |
KR970707108A (ko) | 1997-12-01 |
US5510361A (en) | 1996-04-23 |
NO971789L (no) | 1997-06-19 |
MX9702941A (es) | 1997-07-31 |
KR100226509B1 (ko) | 1999-10-15 |
FI971674A (fi) | 1997-04-18 |
WO1996012710A1 (en) | 1996-05-02 |
EP0787130A1 (en) | 1997-08-06 |
AU3859895A (en) | 1996-05-15 |
JPH10507754A (ja) | 1998-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5354A (is) | Ný efnasambönd | |
FI972970A (fi) | Uusia yhdisteitä | |
DK0777671T3 (da) | Spiro-azabicykliske forbindelser | |
IS2027B (is) | Ný spíróasabísýklísk heterósýklísk efnasambönd | |
BR9509760A (pt) | Composto | |
FI960519A0 (fi) | Uusia yhdisteitä | |
IS5522A (is) | Ný bispidínsambönd við hjartsláttartruflunum | |
FI971674A0 (fi) | Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina | |
DK0820451T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
EE9800430A (et) | Uued ühendid | |
FI970151A (fi) | Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä | |
BR9509740A (pt) | Compostos 18-nor-vitamina d | |
IS4932A (is) | Ný efnasambönd | |
SE9403728D0 (sv) | New compounds | |
SE9402838D0 (sv) | New compounds | |
SE9402813D0 (sv) | New compounds | |
SE9402170D0 (sv) | New compounds | |
NO962535D0 (no) | Di-tert-butylfenolforbindelser anvendbare som antiflammatoriske midler | |
DK0851865T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
SE9702746D0 (sv) | New compounds | |
SE9702747D0 (sv) | New compounds | |
SE9704839D0 (sv) | New compounds | |
SE9701220D0 (sv) | New compounds | |
SE9702378D0 (sv) | New compounds | |
SE9702535D0 (sv) | New compounds |